Novel antiplatelet agent use for acute coronary syndrome in the emergency department: a review

about

The antidepressant 5-HT2A receptor antagonists pizotifen and cyproheptadine inhibit serotonin-enhanced platelet function

P2860

Q28539110-464DE1C4-A369-478B-8393-24156AAA5CE2

P2860

Novel antiplatelet agent use for acute coronary syndrome in the emergency department: a review

Item

http://www.wikidata.org/entity/Q36676694

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Novel antiplatelet agent use f ...... emergency department: a review

@ast

Novel antiplatelet agent use f ...... emergency department: a review

@en

type

Item

label

Novel antiplatelet agent use f ...... emergency department: a review

@ast

Novel antiplatelet agent use f ...... emergency department: a review

@en

prefLabel

Novel antiplatelet agent use f ...... emergency department: a review

@ast

Novel antiplatelet agent use f ...... emergency department: a review

@en

P1476

Novel antiplatelet agent use f ...... emergency department: a review

@en

P2093

E Nath

http://www.w3.org/2001/XMLSchema#string

M Curial

http://www.w3.org/2001/XMLSchema#string

P2860

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment el

The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI

Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial

Clopidogrel resistance?

Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial

ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study.

P304

127270

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2013/127270

http://www.w3.org/2001/XMLSchema#string

P478

2013

http://www.w3.org/2001/XMLSchema#string

P50

Eddy S. Lang

P577

2013-02-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236062062

http://www.w3.org/2001/XMLSchema#string

P698

23509665

http://www.w3.org/2001/XMLSchema#string

P932

3594944

http://www.w3.org/2001/XMLSchema#string

Novel antiplatelet agent use for acute coronary syndrome in the emergency department: a review

about

P2860

P2860

Novel antiplatelet agent use for acute coronary syndrome in the emergency department: a review

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P932